InvestorsHub Logo
Followers 5
Posts 475
Boards Moderated 0
Alias Born 09/27/2012

Re: dia76ca post# 181051

Wednesday, 06/25/2014 1:21:26 AM

Wednesday, June 25, 2014 1:21:26 AM

Post# of 345997
Kind of runs contrary to the narrative that there is no scientific promise and management is doing nothing more than running the ATM and other financing vehicles simply to preserve their own salaries while producing nothing of value to shareholders. Guessing that at least one particular "financial media" sock puppet will have his panties in a bunch now...


"With the anticipated success of this trial, Peregrine expected to promptly partner with or be acquired by a global pharmaceutical company and move into a Phase III trial for NSCLC patients and commence other trials. Bavituximab could be potentially developed for or as a cancer vaccine. Bavituximab also has indications of benefit for other diseases such as Hepatitis C and HTV."

1. PPHM was close to a partnership or acquisition.

2. Bavi could be developed into a vaccine(or combined with a vaccine). Elsewhere it is stated that Bavi might be used in the PREVENTION of cancer!

3. The viral indications still have potential.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News